The diverse impacts of SLC16A1-AS1 in breast cancer, particularly in TNBC, point to its potential as a multifaceted target for therapeutic interventions, with the possibility of manipulating its expression or function to impede cancer progression. The gene discussed is SLC16A1; the disease is breast carcinoma.